Latest News

IonQ is a leading quantum computing firm, poised to more than double full-year revenues amid rapid market evolution. IONQ's quantum solutions are integrated into major cloud platforms, targeting enter

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Chewy NYSE: CHWY is prioritizing U.S. health services, customer spending expansion and artificial intelligence capabilities as it seeks to build on its pet retail foundation, Chief Executive Officer S

OpenAI wants more lawyers to use its AI. To that end, it's partnered with a new startup to give it boots on the ground inside law firms.

Treasury Secretary Scott Bessent's testimony before the House Financial Services Committee is formally focused on the international financial system and the IMF, but lawmakers are expected to question

Toronto, Ontario--(Newsfile Corp. - September 15, 2026) - Arizona Eagle Mining Corp. (TSXV: AZEM) (OTCQB: AZEMF) (the "Company" or "Arizona Eagle") is pleased to announce results of a recent surface s

Zefiro was Sole Bidder on Two of Three Awards; Combined Value of Contracts is Approximately US$1.9 Million Bradford, Pennsylvania--(Newsfile Corp. - September 15, 2026) - Zefiro Methane Corp. (CBOE CA

Sabra Health Care REIT is rated 'Buy' with a $24.50/share price target, reflecting undervaluation and strong fundamentals. SBRA reported robust Q2 results: 24.7% revenue growth, 13.7% same-store manag

I rate Arista Networks a Buy, supported by robust AI networking demand, campus/enterprise expansion, and competitive differentiation via EOS and CloudVision platforms. AI networking is expanding into

American Tower is rated a Strong Buy, trading near 52-week lows with a dividend yield close to a decade high. AMT's resilient business model, long-term leases, and growing data center segment underpin

Vanguard International High Dividend Yield ETF is a buy at $105.60, despite a 19.7% YTD gain, due to robust financials exposure. VYMI's 43.6% allocation to financials aligns with rising global rates a

I maintain the Hold rating on the Franklin U.S. Low Volatility High Dividend Index ETF, which reflects my skeptical stance on the low beta/value combination. LVHD's low volatility and value approach o

Buru Energy Limited (BRNGF) Discusses Recent Announcements and Progress on Rafael Gas and Ungani Oil Projects Transcript

Microsoft is still at least properly valued, if not discounted, after a 27% six-month rally and strong recent earnings. AI fears have largely cleared, with Azure growth accelerating to 43% and managem

Meta Platforms earns a Buy rating at $648, with a 2029 valuation target of $920 based on normalized EPS of $46 and a 20x multiple. AI-driven advertising improvements have delivered measurable gains, b

Corbus Pharmaceuticals NASDAQ: CRBP reported top-line results from CANYON-1, a Phase 1b trial evaluating CRB-913, an oral, peripherally restricted CB1 inverse agonist for obesity. The 12-week, placebo

Health Care sentiment shifted meaningfully during the second quarter of 2026. During the second quarter, the Harbor Health Care ETF (“ETF”) returned 15.30%. Biotechnology was the largest contributor t

One Stop Systems is rated Buy at $9.19, with a fair value of $10.52 per share, offering limited upside of 14.5%. OSS's investment thesis hinges on converting prototype programs into repeat production

Challenger Gold Limited (CLLEF) Shareholder/Analyst Call Transcript

Vanguard Intermediate-Term Treasury ETF is at the confluence of long-term and short-term rate speculation, both with upsides. As far as low-risk investments go, VGIT is at risk of being hobbled by exp